Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin's Lymphoma.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27992551)

Published in PLoS One on December 19, 2016

Authors

Harry Comber1, Marianna De Camargo Cancela2, Trutz Haase3, Howard Johnson4, Linda Sharp5, Jonathan Pratschke6

Author Affiliations

1: National Cancer Registry, Cork, Ireland.
2: Brazilian National Cancer Institute, Epidemiology Division, Rio de Janeiro, Brazil.
3: Social and Economic Consultant, Dublin, Ireland.
4: Health & Wellbeing Directorate Health Intelligence Unit, Health Service Executive, Dublin, Ireland.
5: Institute of Health & Society, Newcastle University, Newcastle upon Tyne, United Kingdom.
6: Department of Economics and Statistics, University of Salerno, Salerno, Italy.

Articles cited by this

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med (2002) 19.60

Marital status and survival in patients with cancer. J Clin Oncol (2013) 5.82

Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer (2009) 5.10

Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. Lancet Oncol (2013) 5.04

Are the serious problems in cancer survival partly rooted in gatekeeper principles? An ecologic study. Br J Gen Pract (2011) 4.28

Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol (2005) 4.07

Socioeconomic differences in cancer survival: a review of the evidence. IARC Sci Publ (1997) 2.33

CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol (2007) 2.17

Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. Lancet Oncol (2014) 1.98

Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands. Ann Oncol (1996) 1.76

Socio-economic deprivation and survival of non-Hodgkin lymphoma in Scotland. Leuk Lymphoma (2008) 1.58

Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma. Cancer (2008) 1.53

Breast cancer awareness and barriers to symptomatic presentation among women from different ethnic groups in East London. Br J Cancer (2011) 1.39

The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009. Cancer Epidemiol Biomarkers Prev (2013) 1.27

The role of the family in treatment decision making by patients with cancer. Oncol Nurs Forum (2003) 1.22

The combined effect of individual and neighborhood socioeconomic status on cancer survival rates. PLoS One (2012) 1.12

Ongoing improvement in outcomes for patients diagnosed as having Non-Hodgkin lymphoma from the 1990s to the early 21st century. Arch Intern Med (2008) 1.08

Socio-economic inequalities: a review of methodological issues and the relationships with cancer survival. Crit Rev Oncol Hematol (2012) 1.06

Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011. Am J Hematol (2015) 1.02

The Association between Fatalistic Beliefs and Late Stage at Diagnosis of Lung and Colorectal Cancer. Cancer Epidemiol Biomarkers Prev (2015) 0.99

The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002. Cancer (2006) 0.98

Social inequality and incidence of and survival from Hodgkin lymphoma, non-Hodgkin lymphoma and leukaemia in a population-based study in Denmark, 1994-2003. Eur J Cancer (2008) 0.96

Facilitators and barriers to help-seeking for breast and cervical cancer symptoms: a qualitative study with an ethnically diverse sample in London. Psychooncology (2013) 0.96

Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC). Am J Clin Oncol (2006) 0.95

The relative length of the patient and the primary care interval in patients with 28 common and rarer cancers. Br J Cancer (2015) 0.93

Cancer-specific variation in emergency presentation by sex, age and deprivation across 27 common and rarer cancers. Br J Cancer (2015) 0.93

Marital status and head and neck cancer outcomes. Cancer (2014) 0.93

Quantifying the risk of non-Hodgkin lymphoma in symptomatic primary care patients aged ≥40 years: a large case-control study using electronic records. Br J Gen Pract (2015) 0.90

Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark--a nationwide study. Br J Cancer (2012) 0.90

Health Insurance-Related Disparities in Lymphoma Survival Are Partly Mediated by Baseline Clinical Factors. Oncologist (2015) 0.89

The Charlson comorbidity index can be used prospectively to identify patients who will incur high future costs. PLoS One (2014) 0.89

International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0-19 years. Int J Cancer (2015) 0.87

Delay in the diagnosis of testicular tumours - changes over the past 18 years. Br J Gen Pract (2004) 0.86

Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma. Cancer Epidemiol (2015) 0.85

Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma. J Registry Manag (2012) 0.84

Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: analysis of a national clinical database. Eur J Cancer (2010) 0.84

US trends in survival disparities among adolescents and young adults with non-Hodgkin lymphoma. Cancer Causes Control (2015) 0.83

Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989-2010. Haematologica (2014) 0.83

Completeness of case ascertainment at the Irish National Cancer Registry. Ir J Med Sci (2013) 0.82

Recent cancer survival in Germany: an analysis of common and less common cancers. Int J Cancer (2014) 0.82

Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study. Eur J Cancer (2015) 0.82

Influence of marital status on the survival of patients with gastric cancer. J Gastroenterol Hepatol (2016) 0.81

Socio-economic factors and health care system characteristics related to cancer survival in the elderly. A population-based analysis in 16 European countries (ELDCARE project). Crit Rev Oncol Hematol (2005) 0.81

Persistent Disparities Among Patients With T-Cell Non-Hodgkin Lymphomas and B-Cell Diffuse Large Cell Lymphomas Over 40 Years: A SEER Database Review. Clin Lymphoma Myeloma Leuk (2015) 0.80

Risk of several cancers is higher in urban areas after adjusting for socioeconomic status. Results from a two-country population-based study of 18 common cancers. J Urban Health (2014) 0.80

'Underclassism' and access to healthcare in urban centres. Sociol Health Illn (2015) 0.79

Total registration of non-Hodgkin's lymphoma and Hodgkin's disease in Scotland: effect of deprivation and caseload on outcome. Hematology (2003) 0.78

Delay in Diagnosis of Testicular Cancer; A Need for Awareness Programs. PLoS One (2015) 0.77

Mechanisms and mediation in survival analysis: towards an integrated analytical framework. BMC Med Res Methodol (2016) 0.77

Women, disadvantage and health. Ir Med J (2007) 0.76

Epidemic of non-hodgkin lymphoma in new zealand remains unexplained. J Cancer Epidemiol (2014) 0.76

Factors driving inequality in prostate cancer survival: a population based study. PLoS One (2014) 0.76

Testicular Cancer Awareness and Knowledge: Is It the Same? Exploratory Study in a Mixed-Gender Population. J Cancer Educ (2017) 0.76

Which women with breast cancer do, and do not, undergo receptor status testing? A population-based study. Cancer Epidemiol (2015) 0.76

Contribution of health behaviors to the association between area-level socioeconomic status and cancer mortality. Soc Sci Med (2015) 0.76